Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2014

Mar 18, 2014

29831_dirs_2014-03-18_a18204e6-9398-45ac-a4e7-dbab8bade3f9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2014-03-14

Reporting Person: YOUNG JOHN D (Group President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-03-17 Common Stock S 9000.0000 $31.3800 Disposed 99647.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-03-14 Phantom Stock Units SSP $ A 1486.0000 Acquired Common Stock (1486.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1056.0000 Indirect
Common Stock 1279.0000 Indirect

Footnotes

F1: Each unit represents one phantom share of common stock.

F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.